Edition:
United States

Abbott Laboratories (ABT)

ABT on New York Consolidated

62.80USD
17 Jul 2018
Change (% chg)

$1.02 (+1.65%)
Prev Close
$61.78
Open
$61.84
Day's High
$63.26
Day's Low
$61.55
Volume
7,435,301
Avg. Vol
5,586,044
52-wk High
$64.60
52-wk Low
$48.05

Latest Key Developments (Source: Significant Developments)

Abbott Laboratories Says Redeemed $1.3 Bln Of $1.8 Bln Outstanding Aggregate Principal Amount Of 2.35% Notes
Friday, 22 Jun 2018 05:05pm EDT 

June 22 (Reuters) - Abbott Laboratories ::ABBOTT LABORATORIES SAYS REDEEMED $1.30 BILLION OF $1.80 BILLION OUTSTANDING AGGREGATE PRINCIPAL AMOUNT OF ITS 2.350% NOTES DUE 2019 - SEC FILING.  Full Article

Abbott Laboratories Says Launched Its Afinion 2 Analyzer In U.S.
Thursday, 31 May 2018 08:00am EDT 

May 31 (Reuters) - Abbott Laboratories ::ABBOTT LABORATORIES - LAUNCH OF ITS AFINION 2 ANALYZER IN U.S..  Full Article

Abbott Laboratories Says Shareholders Rejected Proposal Requesting Board Of Directors Adopt Policy That Board Chairman Be Independent Director
Monday, 30 Apr 2018 05:35pm EDT 

April 30 (Reuters) - Abbott Laboratories ::ABBOTT LABORATORIES SAYS SHAREHOLDERS REJECTED PROPOSAL REQUESTING CO'S BOARD OF DIRECTORS ADOPT POLICY THAT BOARD CHAIRMAN BE INDEPENDENT DIRECTOR.  Full Article

Abbott Laboratories - Co, Sanquin Sign Multiple-Year Contract For Supply Of Primary Serological Equipment And Consumables
Monday, 23 Apr 2018 09:00am EDT 

April 23 (Reuters) - Abbott Laboratories ::ABBOTT LABORATORIES - CO, SANQUIN SIGN MULTIPLE-YEAR CONTRACT FOR SUPPLY OF PRIMARY SEROLOGICAL EQUIPMENT AND CONSUMABLES.  Full Article

Abbott Initiates Groundbreaking Study To Assess Superiority Of High-Resolution Imaging Versus Standard-Of Care Angiography In Treating Coronary Artery Disease
Wednesday, 11 Apr 2018 09:00am EDT 

April 11 (Reuters) - Abbott Laboratories ::CARE ANGIOGRAPHY IN TREATING CORONARY ARTERY DISEASE.RESOLUTION IMAGING RESULT IN LARGER VESSEL DIAMETERS.  Full Article

Mylan To Complete $1 Billion Share Repurchase Plan
Monday, 8 Jan 2018 07:30am EST 

Jan 8 (Reuters) - Mylan Nv ::MYLAN TO COMPLETE $1 BILLION SHARE REPURCHASE PLAN.MYLAN - AS PER AGREEMENT WITH ABBOTT RELATED TO ABBOTT EPD DEAL, ABBOTT NOTIFIED MYLAN IT SOLD REMAINING 20.3 MILLION IN MYLAN SHARES PRIOR TO YEAR-END​.  Full Article

Abbott gets New FDA Labeling For Some Of Its MRI-Ready Devices
Wednesday, 3 Jan 2018 09:00am EST 

Jan 3 (Reuters) - Abbott Laboratories ::NEW FDA MR-CONDITIONAL LABELING APPROVALS FURTHER EXPAND ABBOTT'S PORTFOLIO OF MRI-READY DEVICES.  Full Article

Abbott Increases Quarterly Dividend To 28 Cents Per Share
Friday, 15 Dec 2017 10:17am EST 

Dec 15 (Reuters) - Abbott Laboratories ::ABBOTT LABORATORIES - INCREASED COMPANY'S QUARTERLY COMMON DIVIDEND TO 28 CENTS PER SHARE FROM 26.5 CENTS PER SHARE.  Full Article

Abbott gets FDA clearance for its Alinity ci-series instruments
Tuesday, 31 Oct 2017 09:00am EDT 

Oct 31 (Reuters) - Abbott Laboratories :Abbott announces FDA clearance for its Alinity ci-series next-generation diagnostic systems.Abbott laboratories - ‍secured U.S. FDA 510(k) clearance for its alinity ci-series instruments for clinical chemistry and immunoassay diagnostics​.  Full Article

Abbott says ‍secured FDA clearance for confirm Rx Insertable Cardiac Monitor​
Monday, 23 Oct 2017 09:00am EDT 

Oct 23 (Reuters) - Abbott Laboratories :Abbott - ‍secured FDA clearance for confirm Rx Insertable Cardiac Monitor​.  Full Article

Photo

Allergan appoints former Abbott executive to its board

Allergan Plc said on Thursday former Abbott Laboratories executive Thomas Freyman will join its board, a week after two of its shareholders criticized the drugmaker's acquisition strategy and board composition.